Suchergebnisse

Arzt, Arzneimittel und Selbstmedikation aus der Sicht der
Bevölkerung.

Themen: Zusammensetzung der Hausapotheke; Einkaufshäufigkeit von
Arzneimitteln; detaillierte Angaben über die Art von gesundheitlichen
Beschwerden im letzten Jahr; Verhalten bei Zahnbeschwerden und
Häufigkeit des Zahnarztbesuches; Familienarzt oder Individualarzt;
Bedeutung und Fachrichtung des Hausarztes; Fachrichtung der in Anspruch
genommenen Ärzte; Beurteilung der Einflußnahme der Werbung für
Pharmaartikel auf die Verordnungspraxis des Arztes; Einkaufsquellen für
Arzneimittel allgemein und für durch Pharmawerbung veranlaßte
Selbstmedikationen; Vertrauen in Medien oder Personen bei der
Arzneimittelempfehlung; Wunschverordnung von Arzneimitteln; Art der
Beschwerden, gegen die ein gewünschtes Mittel verschrieben wurde;
Verordnung von Arzneimitteln, die selbst zu zahlen waren; Begründung des
Arztes für die Selbstzahlung; Gesundheitsbeschwerden und
Anwendungsverhalten bei überreichten Ärztemustern; Verhalten bei
leichten Beschwerden und Art verwendeter Hausmittel; Verwendung nicht
verbrauchter Arzneimittel; Kenntnis über die Verderblichkeit von
Tabletten, Dragees und Säften; vermeintliche Ursachen körperlicher
Beschwerden; Teilnahme an Schutzimpfungen und Vorsorgeuntersuchungen;
Art der Beschwerden und Verhalten bei Wetterfühligkeit;
Schmerzempfinden, Schmerzlokalisation und Selbsthilfemaßnahmen.

Demographie: Alter; Familienstand; Konfession; Schulbildung; Beruf;
Berufstätigkeit; Haushaltseinkommen; Haushaltsgröße;
Haushaltungsvorstand.

Intro -- FrontMatter -- Reviewers -- Preface -- Contents -- Boxes and Figures -- Acronyms and Abbreviations -- Summary -- 1 Introduction -- 2 The Effectiveness of Medication-Based Treatment for Opioid Use Disorder -- 3 Treatment with Medications for Opioid Use Disorder in Different Populations -- 4 Medications for Opioid Use Disorder in Various Treatment Settings -- 5 Barriers to Broader Use of Medications to Treat Opioid Use Disorder -- Appendix A: Study Approach and Methods -- Appendix B: Public Workshop Agenda -- Appendix C: Biographical Sketches of Committee Members.

Despite spending more than any other county on incarceration and reentry programs, the United States continues to have some of the highest rates of reincarceration. Programs designed to teach inmates job skills, GED programs, and new Medicaid measures have proved moderately successful for reducing recidivism among certain offenders, but one class continues to suffer high recidivism rates. People imprisoned for opioid drug use are more likely to reoffend than any other group, but very few governments in different countries around the world have allotted the resources to establish effective treatment facilities, creating a cycle very few can escape. This project aims to secure funding from the Montana state government to implement Medication Assisted Treatment (MAT) for opioid drug use in Montana prisons. MAT is a treatment plan that would reduce recidivism rates in Montana in an effective way. With this treatment plan, hopefully opioid users will be able to effectively help reduce recidivism and drug rates by using medical assisted treatment. During the 2021 legislative session, our group lobbied members of the Montana state government through phone calls, emails, and social media to secure support for a bill that provides funding for MAT treatment in prisons. We are a student group from the University of Montana that is a part of the Global Initiative program on campus. We are hoping to accomplish action on the issue of opioid use in the state and help reduce recidivism with this medical assisted treatment plan.

The study is part of the evaluation of measures to reduce the problems associated with the use of illegal drugs in Switzerland (mandate of the Federal Office of Public Health in Bern).
The national customer survey of low-threshold facilities providing injection equipment, conducted in 1993, 1994, 1996 and 2000, provides information on the demographic characteristics and social integration of dependent consumers as well as the substances consumed and the mode of administration used by consumers of this type of facilities.

The study is part of the evaluation of measures to reduce the problems associated with the use of illegal drugs in Switzerland (mandate of the Federal Office of Public Health in Bern).
The national customer survey of low-threshold facilities providing injection equipment, conducted in 1993, 1994, 1996 and 2000, provides information on the demographic characteristics and social integration of dependent consumers as well as the substances consumed and the mode of administration used by consumers of this type of facilities.

The study is part of the evaluation of measures to reduce the problems associated with the use of illegal drugs in Switzerland (mandate of the Federal Office of Public Health in Bern).
The national customer survey of low-threshold facilities providing injection equipment, conducted in 1993, 1994, 1996 and 2000, provides information on the demographic characteristics and social integration of dependent consumers as well as the substances consumed and the mode of administration used by consumers of this type of facilities.

The study is part of the evaluation of measures to reduce the problems associated with the use of illegal drugs in Switzerland (mandate of the Federal Office of Public Health in Bern).
The national customer survey of low-threshold facilities providing injection equipment, conducted in 1993, 1994, 1996 and 2000, provides information on the demographic characteristics and social integration of dependent consumers as well as the substances consumed and the mode of administration used by consumers of this type of facilities.

Description of the Addiction Monitoring project

Addiction Monitoring in Switzerland is an epidemiological monitoring system that was commissioned by the Federal Office of Public Health. It was designed to collect and disseminate information on the behaviour of the resident Swiss population in relation to psychoactive substances (tobacco, alcohol, illegal drugs and medication) and the associated risks (dependency, health damage and psychosocial problems).

The monitoring process comprised three parts:
- An inventory of the data available in Switzerland on dependence
- A continuous rolling survey of members of the public
- A module related to young people's consumption when they go out at the weekend.

Addiction Monitoring in Switzerland was delivered jointly by Sucht Schweiz/Addiction Suisse in Lausanne, the University Institute of Social and Preventive Medicine (Institut universitaire de médecine sociale et préventive, IUMSP) in Lausanne, the Swiss Research Institute for Public Health and Addiction (ISGF) in Zurich and the Social and Market Research Institute (ISBF Switzerland) in Zurich.

The main component of Addiction Monitoring in Switzerland was a continuous rolling survey of addictive behaviours and related risks conducted among members of the public between January 2011 and December 2016. The survey's aim was to fill gaps in the data on the development of addictive behaviour available in Switzerland. For this purpose, each year around 11,000 people age 15 or over resident in Switzerland were contacted by phone (landline and mobile) for an interview of around 25 minutes. Participation in the survey was voluntary, and the data were treated anonymously and in confidence in line with the data protection requirements.